$27.79
0.65% yesterday
Nasdaq, Sep 04, 10:00 pm CET

Quidel Corporation Stock price

$27.79
+3.68 15.26% 1M
-11.18 28.69% 6M
-16.76 37.62% YTD
-12.57 31.14% 1Y
-50.74 64.61% 3Y
-126.62 82.00% 5Y
+6.92 33.16% 10Y
+19.21 223.89% 20Y
Nasdaq, Closing price Thu, Sep 04 2025
+0.18 0.65%

Key metrics

Basic
Market capitalization
$1.9b
Enterprise Value
$4.3b
Net debt
$2.5b
Cash
$151.7m
Shares outstanding
67.7m
Valuation (TTM | estimate)
P/E
negative | 11.4
P/S
0.7 | 0.7
EV/Sales
1.6 | 1.6
EV/FCF
334.0
P/B
0.7
Financial Health
Equity Ratio
46.5%
Return on Equity
-68.8%
ROCE
2.2%
ROIC
2.2%
Debt/Equity
0.9
Financials (TTM | estimate)
Revenue
$2.7b | $2.8b
EBITDA
$309.6m | $602.9m
EBIT
$113.9m | $393.6m
Net Income
$-466.4m | $164.5m
Free Cash Flow
$13.0m
Growth (TTM | estimate)
Revenue
-3.3% | -0.6%
EBITDA
-0.4% | 141.9%
EBIT
8.8% | 759.3%
Net Income
74.9% | 108.0%
Free Cash Flow
107.6%
Margin (TTM | estimate)
Gross
47.3%
EBITDA
11.3% | 21.8%
EBIT
4.2%
Net
-17.0% | 6.0%
Free Cash Flow
0.5%
More
EPS
$-6.9
FCF per Share
$0.2
Short interest
17.8%
Employees
7k
Rev per Employee
$420.0k
Show more

Is Quidel Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Quidel Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Quidel Corporation forecast:

10x Buy
67%
4x Hold
27%
1x Sell
7%

Analyst Opinions

15 Analysts have issued a Quidel Corporation forecast:

Buy
67%
Hold
27%
Sell
7%

Financial data from Quidel Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,742 2,742
3% 3%
100%
- Direct Costs 1,445 1,445
2% 2%
53%
1,297 1,297
4% 4%
47%
- Selling and Administrative Expenses 739 739
5% 5%
27%
- Research and Development Expense 202 202
15% 15%
7%
310 310
0% 0%
11%
- Depreciation and Amortization 196 196
5% 5%
7%
EBIT (Operating Income) EBIT 114 114
9% 9%
4%
Net Profit -466 -466
75% 75%
-17%

In millions USD.

Don't miss a Thing! We will send you all news about Quidel Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Quidel Corporation Stock News

Neutral
GlobeNewsWire
about 15 hours ago
Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In QuidelOrtho (QDEL) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in  QuidelOrtho between February 18, 2022 and April 1, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at ...
Neutral
PRNewsWire
8 days ago
SAN DIEGO , Aug. 28, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team will participate in the Baird 2025 Global Healthcare Conference on Wednesday, September ...
Neutral
PRNewsWire
15 days ago
SAN DIEGO , Aug. 21, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced the completion of a series of related transactions to refinance its debt structure and support future growth. Through these ...
More Quidel Corporation News

Company Profile

Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.

Head office United States
CEO Brian Blaser
Employees 6,600
Founded 2022
Website www.quidelortho.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today